Overnight Rebound is the catalog name associated with sermorelin. Review its proposed purpose and evidence with a clinician rather than treating an anti-aging label as proof of improved health or longevity.
- Format
- Compounded prescription injection
- Price boundary
- Advertised from $99/month
- Evidence basis
- Public catalog plus linked primary guidance
- Review date
- October 8, 2026
What the catalog describes
The provider describes sermorelin as a peptide that signals growth-hormone release and markets it around sleep, recovery and body composition. These are the provider’s descriptions. This publication did not verify a trial of the specific CoreAge Rx preparation or program demonstrating those outcomes.[source]
What the evidence establishes
A biological mechanism is not the same as a clinically meaningful benefit. A change in a hormone measurement would not by itself establish better sleep, improved function or longer life. Ask the clinician which outcome is relevant to you and what research supports the particular proposed use.[source]
Questions for the clinical conversation
The compounded product is not FDA-approved. FDA’s general compounding guidance explains that compounded medicines do not undergo the agency’s premarket review for safety, effectiveness and quality. Historical use of an ingredient does not approve this finished preparation or its wellness marketing.[source]
Practical details to confirm
Clarify the evaluation, follow-up and any laboratory testing that the clinician considers necessary. Ask about contraindications, interactions and how a concern would be handled. No injection schedule or hormone-treatment protocol is supplied in this review.[source]
How to weigh this option
The homepage’s starting quote should be checked against the selected term and any additional evaluation costs. The catalog’s declined-treatment refund exception also matters. Persistent fatigue, sleep difficulty or recovery concerns warrant medical assessment rather than an assumption that a peptide is the appropriate starting point.
Your questions, answered
Is this review based on using the product?
No. It is based on linked public sources. No firsthand treatment experience, clinical outcome or independent laboratory test is claimed.
Does first placement mean it is best for me?
No. CoreAge Rx is featured commercially. Your needs, the exact product and the evidence should guide a discussion with a qualified professional.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx Help Center: current product catalogProvider formulation and consultation information
- CoreAge Rx: current advertised treatments and pricesProvider starting prices; final plan and billing terms require confirmation
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations